Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Story1
OrbiMed-affiliated fund OPI VII reports 12.3% stake in Aspen Neuroscience
A Schedule 13D filed on 6 November 2026 shows OPI VII, a Delaware limited partnership managed by OrbiMed Advisors LLC, holds 3,589,132 shares of Aspen Neuroscience, Inc., equal to approximately 12.3% of the company's outstanding shares.
Company or person20
MAY PETER W
Company
Carter Peter W
Company
MOLL PETER
Company
KASH PETER M
Company
Peter Harf
Person
Feld Peter
Company
Peter Boam
Person
McNamara Peter
Company
Peter Millican
Person
BIERE PETER
Company
Peter A Cox
Person
Behner Peter
Company
Platzer Peter
Company
ADAMEK PETER
Company
Paul May
Person
Mr Ben Peter Delo
Person
Mr Peter Nicolson
Person
CRIST PETER D
Company
Antturi Peter
Company
Herweck Peter
Company
Primary record9
Aspen Neuroscience, Inc. filed SCHEDULE 13D
on October 30, 2026. As of the date of this filing, OPI VII, a limited partnership organized under the laws of Delaware, holds 3,589,132 Shares constituting approximately 12.3% of the issued and outstanding Shares. OrbiM
Wendy's Co filed SCHEDULE 13D/A
0000930413-26-003164.txt : 20261028 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0000930413-26-001914 0001345471 XXXXXXXX LIVE 65 Common Stock, Par Value $.10 Per Share 10/28/2026 false 0000030697 95058W100 The
WATTS WATER TECHNOLOGIES INC filed SCHEDULE 13G/A
on Form 8-K dated October 31, 1991, and to the text of Amendment No. 1 to the Agreement which is incorporated herein by reference to Exhibit 10.21 to the Issuer's Annual Report on Form 10-K dated September 16, 1997. EXHI
ArriVent BioPharma, Inc. filed SCHEDULE 13D/A
(the "SEC") on February 5, 2024 and amended by Amendment No. 1 thereto filed with the SEC on August 13, 2025. This Amendment No. 2 is being filed to report that as a result of the transactions described in Item 5 below,
MAY PETER W filed 4
SEC form 4 filed by MAY PETER W (CIK 928264) on 2026-10-01.
AAR CORP filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As described in Item 5.07 below, on September 23, 2026, at the
DARDEN RESTAURANTS INC filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. (a) The Annual Meeting of Shareholders of the Company (the Annual Meeting ) was held online via the internet at www.virtualshareholdermeeting.com/DRI2026 on
Braveheart Bio, Inc. filed SCHEDULE 13D/A
(the "SEC") on August 18, 2026. This Amendment No. 1 is being filed to report that the percentage of outstanding shares of common stock of the Issuer, par value $0.0001 per share ("Shares") that the Reporting Persons may
ESSENTIAL PROPERTIES REALTY TRUST, INC. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 4, 2026, the Board of Directors (the Board ) of E